A PHASE I, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO ASSESS SAFETY, TOLERABILITY AND PHARMACOKINETICS OF DS-1971A IN HEALTHY MALE SUBJECTS
Phase of Trial: Phase I
Latest Information Update: 14 Aug 2017
At a glance
- Drugs DS-1971 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- Sponsors Daiichi Sankyo Inc
- 20 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Jan 2015 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
- 18 Jul 2014 New trial record